Like_老虎社区_美港股上老虎

brijeshnair
2021-10-15

Generic drug maker Teligent files for bankruptcy protection, explores sale of the company<blockquote>仿制药制造商Teligent申请破产保护，探索出售公司</blockquote>

South Jersey specialty generic pharmaceutical firm Teligent Inc. filed for voluntarily bankruptcy pr

Generic drug maker Teligent files for bankruptcy protection, explores sale of the company<blockquote>仿制药制造商Teligent申请破产保护，探索出售公司</blockquote>

免责声明：上述内容仅代表发帖人个人观点，不构成本平台的任何投资建议。

推荐
最新

暂无评论

热议股票

{"i18n":{"language":"zh_CN"},"data":{"magic":2,"id":824043682,"tweetId":"824043682","gmtCreate":1634264655689,"gmtModify":1634274404389,"author":{"id":4092798624667290,"idStr":"4092798624667290","authorId":4092798624667290,"authorIdStr":"4092798624667290","name":"brijeshnair","avatar":"https://static.tigerbbs.com/7fd087acb258af07a4837fa64d38c77a","vip":1,"userType":1,"introduction":"","boolIsFan":false,"boolIsHead":false,"crmLevel":11,"crmLevelSwitch":0,"individualDisplayBadges":[],"fanSize":1,"starInvestorFlag":false},"themes":[],"images":[],"coverImages":[],"extraTitle":"","html":"<html><head></head><body>Like</body></html>","htmlText":"<html><head></head><body>Like</body></html>","text":"Like","highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":0,"repostSize":0,"favoriteSize":0,"link":"https://laohu8.com/post/824043682","repostId":1182032876,"repostType":4,"repost":{"id":"1182032876","kind":"news","pubTimestamp":1634263136,"share":"https://www.laohu8.com/m/news/1182032876?lang=zh_CN&edition=full","pubTime":"2021-10-15 09:58","market":"us","language":"en","title":"Generic drug maker Teligent files for bankruptcy protection, explores sale of the company<blockquote>仿制药制造商Teligent申请破产保护，探索出售公司</blockquote>","url":"https://stock-news.laohu8.com/highlight/detail?id=1182032876","media":"THE BUSINESS JOURNALS","summary":"South Jersey specialty generic pharmaceutical firm Teligent Inc. filed for voluntarily bankruptcy pr","content":"South Jersey specialty generic pharmaceutical firm Teligent Inc. filed for voluntarily bankruptcy protection on Thursday as it pursues the sale of the company or its core assets.<blockquote>南泽西专业仿制药公司Teligent Inc.周四申请自愿破产保护，寻求出售公司或其核心资产。</blockquote> Teligent Inc. of Buena in Atlantic County also said it is arranging for $12 million debtor-in-possession financing from its senior secured lenders.<blockquote>大西洋县布埃纳的Teligent Inc.也表示，正在安排从其高级担保贷款人处获得1200万美元的债务人持有融资。</blockquote> The company also announced that CEO&nbsp;Tim SawyerandPhilip Yachmetz, Teligent's chief legal officer and executive vice president, resigned effective Oct. 8.<blockquote>该公司还宣布，首席执行官Tim Sawyer和Teligent首席法律官兼执行副总裁Philip Yachmetz于10月8日辞职。</blockquote> Shares of the company are down 47% in pre-market trading Thursday to 18 cents.<blockquote>该公司股价在周四盘前交易中下跌47%，至18美分。</blockquote> Teligent (NASDAQ: TLGT) filed for Chapter 11 in the U.S. Bankruptcy Court for the District of Delaware. The filing does not yet list specific assets and liabilities. It did note AmerisourceBergen (NYSE: ABC) is owed $8.3 million, making the Conshohocken-based wholesale pharmaceutical distributor Teligent's largest unsecured creditor.<blockquote>Teligent（纳斯达克：TLGT）向美国特拉华地区破产法院申请破产法第11章。该文件尚未列出具体的资产和负债。它确实指出，AmerisourceBergen（纽约证券交易所股票代码：ABC）被欠830万美元，使这家总部位于康舍霍肯的药品批发分销商Teligent成为最大的无担保债权人。</blockquote> Teligent began marketing itself ahead of the Chapter 11 filing to determine the level of interest in the company and is in ongoing discussions with several interested parties, the company said. Teligent expects to finalize a sale of the entire business, or its core assets, by early 2022.<blockquote>该公司表示，Teligent在根据美国破产法第11章提交申请之前就开始进行营销，以确定人们对该公司的兴趣程度，并正在与几个感兴趣的各方进行讨论。Teligent预计将在2022年初完成整个业务或其核心资产的出售。</blockquote> \"The entire Teligent team has worked diligently over the past year to address market trends, our debt structure, and operational hurdles that have challenged our business,\" saidJohn Celentano, board chairman of Teligen, in a statement. \"While this is not the outcome we envisioned, we are confident that Teligent's business includes a strong portfolio of specialty generic prescription assets and believe a sale is the best opportunity to maximize value.\"<blockquote>Teligen董事会主席John Celentano在一份声明中表示：“过去一年，整个Teligent团队努力应对市场趋势、债务结构以及对我们业务构成挑战的运营障碍。”“虽然这不是我们设想的结果，但我们相信Teligent的业务包括强大的专业仿制药处方资产组合，并相信出售是实现价值最大化的最佳机会。”</blockquote> Last year, Teligent generated revenue of $45.3 million and a net loss of $122 million. In 2019, it had sales of nearly $65.9 million and a loss of $25.1 million.<blockquote>去年，Teligent营收为4530万美元，净亏损为1.22亿美元。2019年，其销售额近6590万美元，亏损2510万美元。</blockquote> Teligent has spent the past two years engaged in remediation efforts for its South Jersey manufacturing plant after the Food and Drug Administration cited deficiencies at the plant in a warning letter issued to the company in November 2019. Teligent halted its production of certain undisclosed products while it continues to work to address the FDA's concerns.<blockquote>在美国食品和药物管理局在2019年11月向该公司发出的警告信中指出该工厂存在缺陷后，Teligent在过去两年中一直致力于对其南泽西制造工厂进行补救工作。Teligent停止了某些未公开产品的生产，同时继续努力解决FDA的担忧。</blockquote> The company's use of its newly constructed sterile injectable manufacturing plant has also been delayed because of the uncertainty regarding the timing the&nbsp;FDA's inspection of the site.<blockquote>由于FDA检查该工厂的时间存在不确定性，该公司新建的无菌注射剂制造厂的使用也被推迟。</blockquote> Last month, Teligent issued a voluntary recall for a Lidocaine product because of a potency issue. The company has not received any reports of adverse events related to this recall.<blockquote>上个月，由于效力问题，Teligent主动召回了一款利多卡因产品。公司尚未收到任何与本次召回相关的不良事件报告。</blockquote> In connection with the bankruptcy filing, Teligent appointed&nbsp;Vladimir Kasparov, managing director at Portage Point Partners, as chief restructuring officer.<blockquote>关于破产申请，Teligent任命Portage Point Partners董事总经理Vladimir Kasparov为首席重组官。</blockquote> Founded in 1977, Teligent markets more than three dozen generic topical pharmaceutical products formulated as ointments, creams, lotions and gels. The company has over 140 employees, including 114 in Canada.<blockquote>Teligent成立于1977年，销售三打以上软膏、乳膏、洗液和凝胶形式的非专利外用药品。该公司拥有140多名员工，其中114名在加拿大。</blockquote> The company's Canadian affiliate, Teligent Canada, will be pursuing an out-of-court sale process.<blockquote>该公司的加拿大子公司Teligent Canada将寻求庭外出售程序。</blockquote>","source":"lsy1633760424806","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Generic drug maker Teligent files for bankruptcy protection, explores sale of the company<blockquote>仿制药制造商Teligent申请破产保护，探索出售公司</blockquote></title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nGeneric drug maker Teligent files for bankruptcy protection, explores sale of the company<blockquote>仿制药制造商Teligent申请破产保护，探索出售公司</blockquote>\n</h2>\n<h4 class=\"meta\">\n\nTHE BUSINESS JOURNALS2021-10-15 09:58\n\n</h4>\n</header>\n<article>\nSouth Jersey specialty generic pharmaceutical firm Teligent Inc. filed for voluntarily bankruptcy protection on Thursday as it pursues the sale of the company or its core assets.<blockquote>南泽西专业仿制药公司Teligent Inc.周四申请自愿破产保护，寻求出售公司或其核心资产。</blockquote> Teligent Inc. of Buena in Atlantic County also said it is arranging for $12 million debtor-in-possession financing from its senior secured lenders.<blockquote>大西洋县布埃纳的Teligent Inc.也表示，正在安排从其高级担保贷款人处获得1200万美元的债务人持有融资。</blockquote> The company also announced that CEO&nbsp;Tim SawyerandPhilip Yachmetz, Teligent's chief legal officer and executive vice president, resigned effective Oct. 8.<blockquote>该公司还宣布，首席执行官Tim Sawyer和Teligent首席法律官兼执行副总裁Philip Yachmetz于10月8日辞职。</blockquote> Shares of the company are down 47% in pre-market trading Thursday to 18 cents.<blockquote>该公司股价在周四盘前交易中下跌47%，至18美分。</blockquote> Teligent (NASDAQ: TLGT) filed for Chapter 11 in the U.S. Bankruptcy Court for the District of Delaware. The filing does not yet list specific assets and liabilities. It did note AmerisourceBergen (NYSE: ABC) is owed $8.3 million, making the Conshohocken-based wholesale pharmaceutical distributor Teligent's largest unsecured creditor.<blockquote>Teligent（纳斯达克：TLGT）向美国特拉华地区破产法院申请破产法第11章。该文件尚未列出具体的资产和负债。它确实指出，AmerisourceBergen（纽约证券交易所股票代码：ABC）被欠830万美元，使这家总部位于康舍霍肯的药品批发分销商Teligent成为最大的无担保债权人。</blockquote> Teligent began marketing itself ahead of the Chapter 11 filing to determine the level of interest in the company and is in ongoing discussions with several interested parties, the company said. Teligent expects to finalize a sale of the entire business, or its core assets, by early 2022.<blockquote>该公司表示，Teligent在根据美国破产法第11章提交申请之前就开始进行营销，以确定人们对该公司的兴趣程度，并正在与几个感兴趣的各方进行讨论。Teligent预计将在2022年初完成整个业务或其核心资产的出售。</blockquote> \"The entire Teligent team has worked diligently over the past year to address market trends, our debt structure, and operational hurdles that have challenged our business,\" saidJohn Celentano, board chairman of Teligen, in a statement. \"While this is not the outcome we envisioned, we are confident that Teligent's business includes a strong portfolio of specialty generic prescription assets and believe a sale is the best opportunity to maximize value.\"<blockquote>Teligen董事会主席John Celentano在一份声明中表示：“过去一年，整个Teligent团队努力应对市场趋势、债务结构以及对我们业务构成挑战的运营障碍。”“虽然这不是我们设想的结果，但我们相信Teligent的业务包括强大的专业仿制药处方资产组合，并相信出售是实现价值最大化的最佳机会。”</blockquote> Last year, Teligent generated revenue of $45.3 million and a net loss of $122 million. In 2019, it had sales of nearly $65.9 million and a loss of $25.1 million.<blockquote>去年，Teligent营收为4530万美元，净亏损为1.22亿美元。2019年，其销售额近6590万美元，亏损2510万美元。</blockquote> Teligent has spent the past two years engaged in remediation efforts for its South Jersey manufacturing plant after the Food and Drug Administration cited deficiencies at the plant in a warning letter issued to the company in November 2019. Teligent halted its production of certain undisclosed products while it continues to work to address the FDA's concerns.<blockquote>在美国食品和药物管理局在2019年11月向该公司发出的警告信中指出该工厂存在缺陷后，Teligent在过去两年中一直致力于对其南泽西制造工厂进行补救工作。Teligent停止了某些未公开产品的生产，同时继续努力解决FDA的担忧。</blockquote> The company's use of its newly constructed sterile injectable manufacturing plant has also been delayed because of the uncertainty regarding the timing the&nbsp;FDA's inspection of the site.<blockquote>由于FDA检查该工厂的时间存在不确定性，该公司新建的无菌注射剂制造厂的使用也被推迟。</blockquote> Last month, Teligent issued a voluntary recall for a Lidocaine product because of a potency issue. The company has not received any reports of adverse events related to this recall.<blockquote>上个月，由于效力问题，Teligent主动召回了一款利多卡因产品。公司尚未收到任何与本次召回相关的不良事件报告。</blockquote> In connection with the bankruptcy filing, Teligent appointed&nbsp;Vladimir Kasparov, managing director at Portage Point Partners, as chief restructuring officer.<blockquote>关于破产申请，Teligent任命Portage Point Partners董事总经理Vladimir Kasparov为首席重组官。</blockquote> Founded in 1977, Teligent markets more than three dozen generic topical pharmaceutical products formulated as ointments, creams, lotions and gels. The company has over 140 employees, including 114 in Canada.<blockquote>Teligent成立于1977年，销售三打以上软膏、乳膏、洗液和凝胶形式的非专利外用药品。该公司拥有140多名员工，其中114名在加拿大。</blockquote> The company's Canadian affiliate, Teligent Canada, will be pursuing an out-of-court sale process.<blockquote>该公司的加拿大子公司Teligent Canada将寻求庭外出售程序。</blockquote>\n<div class=\"bt-text\">\n\n\n 来源：<a href=\"https://www.bizjournals.com/philadelphia/news/2021/10/14/teligent-buena-south-jersey-chapter-11-bankruptcy.html?ana=yahoo\">THE BUSINESS JOURNALS</a>\n为提升您的阅读体验，我们对本页面进行了排版优化\n\n\n</div>\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{},"source_url":"https://www.bizjournals.com/philadelphia/news/2021/10/14/teligent-buena-south-jersey-chapter-11-bankruptcy.html?ana=yahoo","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1182032876","content_text":"South Jersey specialty generic pharmaceutical firm Teligent Inc. filed for voluntarily bankruptcy protection on Thursday as it pursues the sale of the company or its core assets.\nTeligent Inc. of Buena in Atlantic County also said it is arranging for $12 million debtor-in-possession financing from its senior secured lenders.\nThe company also announced that CEO Tim SawyerandPhilip Yachmetz, Teligent's chief legal officer and executive vice president, resigned effective Oct. 8.\nShares of the company are down 47% in pre-market trading Thursday to 18 cents.\nTeligent (NASDAQ: TLGT) filed for Chapter 11 in the U.S. Bankruptcy Court for the District of Delaware. The filing does not yet list specific assets and liabilities. It did note AmerisourceBergen (NYSE: ABC) is owed $8.3 million, making the Conshohocken-based wholesale pharmaceutical distributor Teligent's largest unsecured creditor.\nTeligent began marketing itself ahead of the Chapter 11 filing to determine the level of interest in the company and is in ongoing discussions with several interested parties, the company said. Teligent expects to finalize a sale of the entire business, or its core assets, by early 2022.\n\"The entire Teligent team has worked diligently over the past year to address market trends, our debt structure, and operational hurdles that have challenged our business,\" saidJohn Celentano, board chairman of Teligen, in a statement. \"While this is not the outcome we envisioned, we are confident that Teligent's business includes a strong portfolio of specialty generic prescription assets and believe a sale is the best opportunity to maximize value.\"\nLast year, Teligent generated revenue of $45.3 million and a net loss of $122 million. In 2019, it had sales of nearly $65.9 million and a loss of $25.1 million.\nTeligent has spent the past two years engaged in remediation efforts for its South Jersey manufacturing plant after the Food and Drug Administration cited deficiencies at the plant in a warning letter issued to the company in November 2019. Teligent halted its production of certain undisclosed products while it continues to work to address the FDA's concerns.\nThe company's use of its newly constructed sterile injectable manufacturing plant has also been delayed because of the uncertainty regarding the timing the FDA's inspection of the site.\nLast month, Teligent issued a voluntary recall for a Lidocaine product because of a potency issue. The company has not received any reports of adverse events related to this recall.\nIn connection with the bankruptcy filing, Teligent appointed Vladimir Kasparov, managing director at Portage Point Partners, as chief restructuring officer.\nFounded in 1977, Teligent markets more than three dozen generic topical pharmaceutical products formulated as ointments, creams, lotions and gels. The company has over 140 employees, including 114 in Canada.\nThe company's Canadian affiliate, Teligent Canada, will be pursuing an out-of-court sale process.","news_type":1,"symbols_score_info":{"TLGT":0.9}},"isVote":1,"tweetType":1,"viewCount":2018,"commentLimit":10,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"symbols":[],"verified":2,"subType":0,"readableState":1,"langContent":"CN","currentLanguage":"CN","warmUpFlag":false,"orderFlag":false,"shareable":true,"causeOfNotShareable":"","featuresForAnalytics":[],"commentAndTweetFlag":false,"andRepostAutoSelectedFlag":false,"upFlag":false,"length":4,"xxTargetLangEnum":"ZH_CN"},"commentList":[],"hasMoreComment":false,"orderType":2}